EVOFEM BIOSCIENCES, INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/38af4bdf-c686-42f0-ab53-5bf4f71409cf/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $3.4M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-009686 |
| FY 2024 | $-7.7M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-000188 |
| FY 2023 | $-17.8M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-011404 |
| FY 2022 | $-84.1M | 2022-01-01 – 2022-12-31 | evidence 0001618835-23-000023 |
| FY 2021 | $-166.8M | 2021-01-01 – 2021-12-31 | evidence 0001618835-22-000057 |
| FY 2020 | $-103.6M | 2020-01-01 – 2020-12-31 | evidence 0001618835-21-000040 |
| FY 2019 | $-52.7M | 2019-01-01 – 2019-12-31 | evidence 0001618835-20-000047 |
| FY 2018 | $-77.6M | 2018-01-01 – 2018-12-31 | evidence 0001618835-19-000031 |
| FY 2017 | $-35.7M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-110108 |
| FY 2016 | $-34.6M | 2016-01-01 – 2016-12-31 | evidence 0001193125-18-110108 |
| FY 2015 | $-42.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-015451 |
| FY 2014 | $-9.6M | 2014-01-01 – 2014-12-31 | evidence 0001564590-16-015451 |
| FY 2013 | $-14.4M | 2013-01-01 – 2013-12-31 | evidence 0001564590-16-015451 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).